Correction of the hyper-IgM syndrome after liver and bone marrow transplantation

New England Journal of Medicine

Volumn 342, Issue 5, 2000, Pages 320-324

  Hadžić, Nedim ^a   Pagliuca, Antonio ^a   Rela, Mohamed ^a   Portmann, Bernard ^a   Jones, Alison ^b   Veys, Paul ^b   Heaton, Nigel D ^a   Mufti, Ghulam J ^a   Mieli Vergani, Giorgina ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

^b HOSPITAL FOR SICK CHILDREN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN;

ARTICLE; BONE MARROW TRANSPLANTATION; CASE REPORT; HUMAN; HYPERIMMUNOGLOBULINEMIA E; IMMUNE DEFICIENCY; IMMUNOCOMPETENCE; LIVER BIOPSY; LIVER TRANSPLANTATION; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADOLESCENT; BONE MARROW TRANSPLANTATION; HUMANS; HYPERGAMMAGLOBULINEMIA; IMMUNOGLOBULIN M; IMMUNOSUPPRESSIVE AGENTS; LIVER; LIVER TRANSPLANTATION; MALE; SEVERE COMBINED IMMUNODEFICIENCY; SYNDROME; TRANSPLANTATION CONDITIONING;

EID: 10644266286     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM200002033420504     Document Type: Article

References (24)

1. Notarangelo LD, Duse M, Ugazio AG. Immunodeficiency with hyper-IgM (HIM), Immunodefic Rev 1992;3:101-21.
2. Grewal IS, Borrow P, Pamcr EG, Oldstone MBA, Flavell RA. The CD40-CD154 system in anti-infective host defence. Curr Opin Immunol 1997;9:491-7.
3. Levy J, Espanol-Boren T, Thomas C, et al. Clinical spectrum of X-linked hyper-IgM syndrome. J Pediatr 1997;131:47-54.
4. Primary immunodeficiency diseases: report of a WHO scientific group. Clin Exp Immunol 1995;99:Suppl 1:2-24.
5. Allen RC, Armitage RJ, Conley ME, et al. CD40 ligand gene defects responsible for X-linked hyper-IgM syndrome. Science 1993;259:990-3.
6. Notarangelo LD, Peitsch MC. CD401base: a database of CD40L gene mutations causing X-linked hyper-IgM syndrome. Immunol Today 1996; 17:511-6.
7. Hayward AR, Levy J, Facchetti F, et al. Cholangiopathy and tumors of the pancreas, liver, and biliary tree in boys with X-linked immunodeficiency with hyper-IgM. J Immunol 1997;158:977-83.
8. Martinez Ibanez V, Espanol T, Matamoros N, et al. Relapse of sclerosing cholangitis after liver transplant in patients with hyper-IgM syndrome. Transplant Proc 1997;29:432-3.
9. Thomas C, de Saint Basile G, Le Deist F, et al. Correction of X-linked hyper-IgM syndrome by allogeneic bone marrow transplantation. N Engl J Med 1995;333:426-9.
10. Giralt S, Estey E, Albitar M, et al. Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: harnessing graft-versus-leukemia without myeloablative therapy. Blood 1997; 89:4531-6.
11. Slavin S, Nagler A, Naparstck E, et al. Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases. Blood 1998;91:756-63.
12. Villa A, Notarangelo LD, Di Santo JP, et al. Organization of the human CD40L gene: implications for molecular defects in X-chromosome-linked hyper-IgM syndrome and prenatal diagnosis. Proc Natl Acad Sci U S A 1994;91:2110-4.
13. Mancuso DJ, Tuley EA, Westfield LA, et al. Structure of the gene for human von Willebrand factor. J Biol Chem 1989;264:19514-27.
14. Kapoor N, Crooks G, Kohn DB, Parkman R. Hematopoietic stem cell transplantation for primary lymphoid immunodeficiencies. Semin Hematol 1998;35:346-53.
15. Hadzic N, Heaton ND, Francavilla R, Davies G, Jones A, Mieli-Vergani G. Paediatric sclerosing cholangitis associated with primary immuno-deficiency. Hepatology 1998;28:Suppl:446A. abstract.
16. Rosen HR, Martin P, Schiller GJ, et al. Orthotopic liver transplantation for bone marrow transplant-associated veno-occlusive disease and graft-versus-host disease of the liver. Liver Transpl Surg 1996;2:225-32.
17. Fuleihan RL. The X-linked hyperimmunoglobulin M syndrome. Semin Hematol 1998;35:321-31.
18. Davis JJ, Heyman MB, Ferrell L, Kerner J, Kerlan R Jr, Thaler MM. Sclerosing cholangitis associated with chronic Cryptosporidiosis in a child with a congenital immunodeficiency disorder. Am J Gastroenterol 1987; 82:1196-202.
19. Petersen C. Cryptosporidiosis in patients infected with the human immunodeficiency virus. Clin Infect Dis 1992;15:903-9.
20. Armitage K, Flanigan T, Carey J, et al. Treatment of Cryptosporidiosis with paromomycin: a report of five cases. Arch Intern Med 1992;152: 2497-9.
21. Hicks P, Zwiener RJ, Squires J, Savell V. Azithromycin therapy for Cryptosporidium parvum infection in four children infected with human immunodeficiency virus. J Pediatr 1996;129:297-300.
22. Blanshard C, Shanson DC, Gazzard BG. Pilot studies of azithromycin, letrazuril and paromomycin in the treatment of cryptosporidiosis. Int J STD AIDS 1997;8:124-9.
23. Nachbaur D, Kropshofer G, Feichtinger H, Allerberger F, Niederwieser D. Cryptosporidiosis after CD34-selected autologous peripheral blood stem cell transplantation (PBSCT): treatment with paromomycin, azithromycin and recombinant human interleukin-2. Bone Marrow Transplant 1997;19:1261-3.
24. Pol S, Romana CA, Richard S, et al. Microsporidia infection in patients with the human immunodeficiency virus and unexplained cholangitis. N Engl J Med 1993;328:95-9.